Evidence map›Paper›PMID 30145671›Full record

Trial reportInternational urogynecology journal2019

Randomized controlled trial of silver-alloy-impregnated suprapubic catheters versus standard suprapubic catheters in assessing urinary tract infection rates in urogynecology patients.

Ruchira Singh, Erik D Hokenstad, Sheila R Wiest, Shunaha Kim-Fine, Amy L Weaver, Michaela E McGree, Christopher J Klingele, Emanuel C Trabuco, John B Gebhart

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in International urogynecology journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ruchira SinghDepartment of Obstetrics and Gynecology, University of Florida, 653-1 W. 8th Street, Jacksonville, FL, 32209, USA. ruchira.26@gmail.com.
Erik D HokenstadDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
Sheila R WiestDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
Shunaha Kim-FineDepartment of Obstetrics and Gynecology, University of Calgary, Calgary, AB, Canada.
Amy L WeaverDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Michaela E McGreeDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
Christopher J KlingeleDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
Emanuel C TrabucoDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
John B GebhartDepartment of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · USMayo Clinic in Florida · USUniversity of Calgary · CAUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisCatheter-associated urinary tract infections (UTI) are the most common health-care-related infections. We aimed to compare the UTI rate among women undergoing urogynecological procedures with a silver-alloy suprapubic catheter (SPC) and a standard SPC, and identify the risk factors predisposing patients to UTI.

methodsPatients who were to undergo placement of an SPC as part of pelvic organ prolapse surgery were enrolled between 1 August 2011 and 30 August 2017, and randomized to either standard SPC or silver-alloy SPC. Follow-up was performed at a postoperative visit or via a phone call at 6 weeks. The primary outcome was UTI.

resultsOf the 288 patients who were randomized, 127 with standard SPC and 137 with silver-alloy SPC were included in the analysis. Twenty-nine out of 123 women with standard SPC (23.6%) and 24 out of 131 (18.3%) with silver-alloy SPC were diagnosed with UTI within 6 weeks postoperatively (p = 0.30). In univariate analysis, non-white race (odds ratio [OR] 5.36, 95% CI 1.16-24.73) and diabetes (OR 2.80, 95% CI 1.26-6.23) were associated with increased risk of UTI. On multivariate analysis, only diabetes remained an independent risk factor. Comparisons between groups were evaluated using two-sample t test for age, Chi-squared tests for diabetes, and Wilcoxon rank sum test for all other variables.

conclusionThere was only a 5% difference in 6-week UTI rates between those who received standard vs silver-alloy SPC; the study was not powered to detect such a small difference. Diabetes was identified as a risk factor for SPC-associated UTI in women undergoing pelvic reconstructive surgeries.

Indexed as

AgedCatheter-Related InfectionsFemaleHumansMiddle AgedPelvic Organ ProlapsePostoperative ComplicationsRisk FactorsSilver CompoundsUrinary CatheterizationUrinary CathetersUrinary Tract InfectionsSilver CompoundsProlapse surgeryRandomized trialSilver-alloy suprapubic catheterUrinary tract infection

Identifiers

PMID30145671
OpenAlexW2887996375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.